Table 2.
Binding energies from redocking simulations of interaction of SIRT1, 2, and 3with the co-crystallized inhibitors.
| Receptor/Inhibitor | Docking Procedure |
Binding Energy (Kcal/mol) |
Interaction Region on the Receptor |
|---|---|---|---|
| SIRT1/EX527 analog a | Blind | −11.07 b | Inhibition site |
| −6.44 b | Binding site | ||
| Focused | −11.25 | Inhibition site | |
| SIRT2/SirReal a | Blind | −10.92 | Inhibition site |
| Focused | −12.39 | Inhibition site | |
| SIRT3/SRT1720 a | Blind | −13.66 | Inhibition site |
| Focused | −13.59 | Inhibition site |
a The structures with PDB codes 4I5I [25], 5DY4 [26], and 4BN5 [27] have been selected for SIRT1, 2, and 3, respectively. All structures present an inhibitor co-crystallized with the protein. b Two clusters of conformations under blind docking simulation are reported because they have different interaction regions on the receptor.